Picture of Koninklijke Philips logo

PHG — Koninklijke Philips News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Netherlands' Philips lifts annual profit, cash flow outlook after US tariff refund

Netherlands' Philips lifts annual profit, cash flow outlook after US tariff refund


Overview

  • Netherlands health tech firm's Q2 sales rose 4% yr/yr to EUR 4.4 bln

  • Operating income increased to EUR 609 mln, boosted by US tariff refund benefit

  • Comparable order intake fell 1% due to timing of large orders shifting to Q3


Outlook

  • Philips sees 2026 comparable sales growth outlook of 3%-4.5%

  • Company raises 2026 adjusted EBITA margin outlook to 13.5%-14.0%, including US tariff refund benefit

  • Philips increases 2026 free cash flow guidance to EUR 1.5-1.7 bln


Result Drivers

  • US TARIFF REFUND - One-off US tariff refund significantly boosted operating income and margins in the quarter

  • ORDER TIMING - Comparable order intake declined 1% due to timing of certain large orders

  • COST INFLATION AND TARIFFS - Excluding the US tariff refund, margins were pressured by cost inflation and higher tariffs, partly offset by productivity measures


Company press release: ID:nGNE7Y0wv4


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

EUR 4.40 bln

Q2 Operating Cash Flow

EUR 376 mln

Q2 Free Cash Flow

EUR 222 mln

Q2 Operating Income

EUR 609 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 12 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

  • Wall Street's median 12-month price target for Koninklijke Philips NV is €27.25, about 15.8% above its July 27 closing price of €23.53

  • The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 15 three months ago


Reuters Recommended Reads

  • July 27 - AstraZeneca Q2 revenue rises 6% on demand for its cancer therapies

  • July 27 - Singapore's Raffles Medical H1 revenue falls 6.7%, profit down 9.8%

  • July 27 - US firms in Europe broadly see stable transatlantic ties a year on from trade deal


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Koninklijke Philips

See all news